Growth hormone secretagogue receptor (GHSR) is expressed in a variety of peripheral organs, the brain, and tumor tissues, making it an important molecular target for both translational imaging and mechanistic studies of GHSR-related physiology and pathology. To date, several GHSR-targeted PET probes have been developed to support disease diagnosis and fundamental research on GHSR function. Recently, a study revealed PET tracer 18FAQ-12 demonstrated favorable properties, including low lipophilicity, comparable binding affinity to existing ligands, and notably higher pancreatic uptake in GHSR-expressing tissue. Importantly, systematic structure–activity relationship analyses of this compound have been clearly delineated, providing valuable insights to guide further ligand optimization and GHSR-targeted drug development.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ruihu Song
Steven H. Liang
ACS Medicinal Chemistry Letters
Emory University
Georgia Institute of Technology
The Wallace H. Coulter Department of Biomedical Engineering
Building similarity graph...
Analyzing shared references across papers
Loading...
Song et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69ba425c4e9516ffd37a285b — DOI: https://doi.org/10.1021/acsmedchemlett.6c00075
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: